Bausch Health
BHC
#3482
Rank
A$4.90 B
Marketcap
$13.25
Share price
-2.23%
Change (1 day)
26.86%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.00

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.11. In 2022 the company made an earnings per share (EPS) of -$0.96 an increase over its 2021 EPS that were of -$4.11.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.00316.54%
2022-$0.96-76.64%
2021-$4.1168.45%
2020-$2.44-68.91%
2019-$7.85-57.11%
2018-$18.31-272.22%
2017$10.63-199.29%
2016-$10.71798.7%
2015-$1.19-128.31%
2014$4.21-204.62%
2013-$4.02602.7%
2012-$0.57-171.15%
2011$0.80-143.96%
2010-$1.83-206.57%
2009$1.72-11.2%
2008$1.932.46%
2007$1.89-7.58%
2006$2.04-14.29%
2005$2.3854%
2004$1.55-500%
2003-$0.39-141.67%
2002$0.93-4.76%
2001$0.97-175%
2000-$1.30-268%
1999$0.7714.94%
1998$0.6720.83%
1997$0.5653.83%
1996$0.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.55-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.42-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA